A recently renewed patent, granted to a prominent biomedical institution in New York City, indicates the existence of a technology capable of "remotely controlling cell functions."
This patent, which was obtained by Rockefeller University in 2018, explains how extremely small particles called "nanoparticles" can be engineered to be directed to specific types of cells, either from outside the cell or by placing them inside it.
Shocking files reveal global elites explored remote human cell control https://t.co/wt2qinRomC
They have been planning this for YEARS. A 2018 Rockefeller University patent (US 10,786,570) reveals how to inject iron oxide nanoparticles into you then BLAST them… pic.twitter.com/cmzXPXCbTF
When these particles are exposed to radio waves, their temperature rises slightly, which activates heat-sensitive channels located within the target cells. This activation, in turn, stimulates a biological response within the cell, such as activating certain genes or producing specific proteins.
According to the patent text, this technology can be used to treat a wide range of diseases and disorders by remotely activating specific cellular functions within the body, without the need for surgery or implanted devices.
Several experiments were conducted on mice to test the effectiveness of this technique. Researchers implanted engineered cells into the mice, designed to secrete insulin when activated. These cells were equipped with heat-sensitive channels and iron oxide nanoparticles. When the mice were exposed to a radiofrequency magnetic field, the particles heated the cells and activated them, causing them to release insulin and thus lowering blood sugar levels without any surgical intervention.
The experiments also involved activating brain cells associated with reward and feeding behavior in areas of the midbrain and hypothalamus responsible for appetite, motivation, and dopamine signaling.
The researchers also tested the technology on genetically modified stem cells, successfully controlling their functions remotely. The patent indicates that the nanoparticles can be injected into the body or even genetically engineered within cells using a naturally occurring human protein called ferritin, which is responsible for iron storage. To ensure safety, the researchers continuously monitored the mice's temperature to confirm that the heating occurred only within the targeted cells without harming surrounding healthy tissue.
While this technology could revolutionize the treatment of diseases such as diabetes, Parkinson's, chronic pain, stroke, hormonal and immune disorders, and some neurological conditions, the patent has sparked concerns and conspiracy theories online. This stems from Rockefeller University's historical ties to the wealthy Rockefeller family, who have long been the subject of allegations regarding their secret influence on global politics and finance and the creation of the so-called "New World Order."
As a result, social media users speculated that this technology could theoretically be misused for neurological control or behavioral manipulation, with one X platform user describing it as: "The plans of the global elite have been fully exposed. Does this patent mean the end of humanity's biological independence?"
However, it is important to emphasize, according to the patent text itself, that there is no evidence that this technology was designed for mind control or population surveillance. Rather, the patent describes purely medical applications aimed at treating diseases by activating specific cellular responses. The scientific term "remote control of cell functions" simply refers to activating biological responses in target cells using radio frequency signals, not to controlling an organism's will.
